[Monthly changes in serum alpha 2-globulin and immunoglobulin levels in chronic hemodialysis patients--with special reference to the occurrence of cancer and blood transfusion].
Thirty-eight patients with chronic renal failure who were treated by hemodialysis more than 100 times each, including 13 cancer patients, were examined for serum alpha 2-globulin and immunoglobulin values monthly, the relationship between the possibility of cancer occurrence and the frequency of blood transfusion during hemodialysis was discussed. The alpha 2-globulin value of the patients treated with blood transfusion more than 20 times was significantly higher than that of the patients not receiving blood transfusion. Moreover, the IgA value was reduced and the IgM value was increased. The IgA values of cancer patients found before or during hemodialysis were significantly higher than those of patients without cancer. There was no significant difference between the group who had undergone hemodialysis more than 500 times those who had received it less than 500 times.
Misao
A
A
Saji
S
S
Hosono
Y
Y
Takekoshi
T
T
Tanaka
S
S
Sato
Y
Y
Mori
N
N
Yasui
S
S
Kuriyama
I
I
D000328:Adult; D000368:Aged; D000510:Alpha-Globulins / Q000032:analysis*; D001803:Blood Transfusion; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007676:Kidney Failure, Chronic / Q000276:immunology* / Q000628:therapy; D007680:Kidney Neoplasms / Q000276:immunology; D008223:Lymphoma / Q000453:epidemiology* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013274:Stomach Neoplasms / Q000453:epidemiology* / Q000276:immunology
D000510:Alpha-Globulins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins